Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 5WPZ | 5WPZ | Crystal structure of MNDA PYD with MBP tag | |
| 5WKT | 5WKT | 3.2-Angstrom In situ Mylar structure of bovine opsin at 100 K | |
| 5WKI | 5WKI | Crystal structure of PG90 TCR-CD1b-PG complex | T-cell surface glycoprotein CD1b, Beta-2-microglobulin, T-cell receptor alpha variable 26-1,TRA@ protein, PG90 TCR beta chain |
| 5WI9 | 5WI9 | Crystal structure of KL with an agonist Fab | Beta-klotho, 39F7 Fab light chain, 39F7 Fab heavy chain |
| 5WDU | 5WDU | HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-46 scFv | |
| 5WB9 | 5WB9 | Crystal structure of CD4 binding site antibody N60P23 in complex with HIV-1 clade A/E strain 93TH057 gp120 core | |
| 5WAV | 5WAV | Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. | Immunoglobulin gamma-1 heavy chain |
| 5WAV | 5WAV | Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. | Immunoglobulin gamma-1 heavy chain |
| 5W9I | 5W9I | MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 | Spike glycoprotein, G4 VH, G4 VL |
| 5W9H | 5W9H | MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4 | MERS S, G4 VH, G4 VL |
| 5W6U | 5W6U | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP121068 (P2) | |
| 5W6T | 5W6T | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP151070 (P7) | |
| 5W6R | 5W6R | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141099 (P6) | |
| 5W6I | 5W6I | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141046 (P3) | |
| 5W6G | 5W6G | Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands | |
| 5W6G | 5W6G | Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands | |
| 5W6D | 5W6D | Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L | |
| 5W5U | 5W5U | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141037 (P4) | |
| 5W5S | 5W5S | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with cyclic peptide CP141019 (P5) | |
| 5W4L | 5W4L | Crystal structure of the non-neutralizing and ADCC-potent C11-like antibody N12-i3 in complex with HIV-1 clade A/E gp120, the CD4 mimetic M48U1, and the antibody N5-i5. | |
| 5W42 | 5W42 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 5W42 | 5W42 | Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2) | |
| 5W1M | 5W1M | MACV GP1 CR1-07 Fab complex | |
| 5W1M | 5W1M | MACV GP1 CR1-07 Fab complex | |
| 5W1K | 5W1K | JUNV GP1 CR1-10 Fab CR1-28 Fab complex | |
| 5W1K | 5W1K | JUNV GP1 CR1-10 Fab CR1-28 Fab complex | |
| 5W0D | 5W0D | Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 | |
| 5W0D | 5W0D | Inferred precursor (UCA) of the human antibody lineage K03.12 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 | |
| 5W08 | 5W08 | A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab | |
| 5W08 | 5W08 | A/Texas/50/2012(H3N2) Influenza hemagglutinin in complex with K03.12 Fab | |
| 5VVX | 5VVX | Structural Investigations of the Substrate Specificity of Human O-GlcNAcase | |
| 5VVV | 5VVV | Structural Investigations of the Substrate Specificity of Human O-GlcNAcase | |
| 5VVU | 5VVU | Structural Investigations of the Substrate Specificity of Human O-GlcNAcase | |
| 5VVT | 5VVT | Structural Investigations of the Substrate Specificity of Human O-GlcNAcase | |
| 5VTA | 5VTA | Co-Crystal Structure of DPPIV with a Chemibody Inhibitor | Dipeptidyl peptidase 4 (E.C.3.4.14.5), Fab light chain, Fab heavy chain |
| 5VQE | 5VQE | Beta-glucoside phosphorylase BglX bound to 2FGlc | |
| 5VPL | 5VPL | CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1 | |
| 5VPG | 5VPG | CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 | |
| 5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5VOD | 5VOD | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 | |
| 5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
| 5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
| 5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
| 5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
| 5VN8 | 5VN8 | Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 | Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain |
| 5VN3 | 5VN3 | Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding variable domain of 17b | 17b Fab light chain, Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
| 5VLI | 5VLI | Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934) | |
| 5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 5VL3 | 5VL3 | CD22 d1-d3 in complex with therapeutic Fab Epratuzumab | B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain |
| 5VK2 | 5VK2 | Structural basis for antibody-mediated neutralization of Lassa virus |
